{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:30:20Z","timestamp":1793626220084,"version":"4.5.1"},"reference-count":35,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjod"],"DOI":"10.4274\/tjod.galenos.2024.59944","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T06:58:29Z","timestamp":1725433109000},"page":"208-218","source":"Crossref","is-referenced-by-count":1,"title":["The effects of growth hormone supplementation in poor ovarian responders undergoing In vitro fertilization or Intracytoplasmic sperm injection: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.4274","author":[{"given":"Faezeh","family":"Zakerinasab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qumars","family":"Behfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Parsaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Arbab Mojeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arina","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar","family":"Deravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Khademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.fertnstert.2004.07.963","article-title":"Agonist \"flare-up\" versus antagonist in the management of poor responders undergoing in vitro fertilization treatment","volume":"83","author":"Mohamed","year":"2005","unstructured":"1. Mohamed KA, Davies WA, Allsopp J, Lashen H. Agonist \"flare-up\" versus antagonist in the management of poor responders undergoing in vitro fertilization treatment. Fertil Steril. 2005;83:331-5.","journal-title":"Fertil Steril"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/GCO.0b013e328305b9b8","article-title":"Poor responder protocols for in-vitro fertilization: options and results","volume":"20","author":"Loutradis","year":"2008","unstructured":"2. Loutradis D, Vomvolaki E, Drakakis P. Poor responder protocols for in-vitro fertilization: options and results. Curr Opin Obstet Gynecol. 2008;20:374-8.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"AP","year":"2011","unstructured":"3. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L; ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616-24.","journal-title":"Hum Reprod"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/humrep\/deu266","article-title":"Ovarian response prediction in GnRH antagonist treatment for IVF using anti-M\u00fcllerian hormone","volume":"30","author":"Hamdine","year":"2015","unstructured":"4. Hamdine O, Eijkemans MJ, Lentjes EW, Torrance HL, Macklon NS, Fauser BC, et al. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-M\u00fcllerian hormone. Hum Reprod. 2015;30:170-8.","journal-title":"Hum Reprod"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10815-008-9212-7","article-title":"Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial","volume":"25","author":"Kucuk","year":"2008","unstructured":"5. Kucuk T, Kozinoglu H, Kaba A. Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. J Assist Reprod Genet. 2008;25:123-7.","journal-title":"J Assist Reprod Genet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1040503","DOI":"10.3389\/fendo.2022.1040503","article-title":"Growth hormone in fertility and infertility: Mechanisms of action and clinical applications","volume":"13","author":"Chang","year":"2022","unstructured":"6. Chang CW, Sung YW, Hsueh YW, Chen YY, Ho M, Hsu HC, et al. Growth hormone in fertility and infertility: Mechanisms of action and clinical applications. Front Endocrinol (Lausanne). 2022;13:1040503.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12020-010-9403-8","article-title":"Extrapituitary growth hormone","volume":"38","author":"Harvey","year":"2010","unstructured":"7. Harvey S. Extrapituitary growth hormone. Endocrine. 2010;38:335-59.","journal-title":"Endocrine"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.8755-8920.2003.00127.x","article-title":"Immunohistochemical localization of the growth hormone in human endometrium and decidua","volume":"51","author":"Sbracia","year":"2004","unstructured":"8. Sbracia M, Scarpellini F, Poverini R, Al\u00f2 PL, Rossi G, Di Tondo U. Immunohistochemical localization of the growth hormone in human endometrium and decidua. Am J Reprod Immunol. 2004;51:112-6.","journal-title":"Am J Reprod Immunol"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Abir R, Garor R, Felz C, Nitke S, Krissi H, Fisch B. Growth hormone and its receptor in human ovaries from fetuses and adults. Fertil Steril. 2008;90(4 Suppl):1333-9.","DOI":"10.1016\/j.fertnstert.2007.08.011"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Bidlingmaier M, Strasburger CJ. Growth hormone. Doping in Sports: Biochemical Principles, Effects and Analysis. 2010: p. 187-200.","DOI":"10.1007\/978-3-540-79088-4_8"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1210\/endo.135.3.8070383","article-title":"Growth hormone stimulates follicular development by stimulating ovarian production of insulin-like growth factor-I","volume":"135","author":"Yoshimura","year":"1994","unstructured":"11. Yoshimura Y, Iwashita M, Karube M, Oda T, Akiba M, Shiokawa S, et al. Growth hormone stimulates follicular development by stimulating ovarian production of insulin-like growth factor-I. Endocrinology. 1994;135:887-94.","journal-title":"Endocrinology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/joe.0.1680001","article-title":"Growth hormone: roles in female reproduction","volume":"168","author":"KL","year":"2001","unstructured":"12. Hull KL, Harvey S. Growth hormone: roles in female reproduction. J Endocrinol. 2001;168:1-23.","journal-title":"J Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1530\/rep.1.00946","article-title":"Reduced recruitment and survival of primordial and growing follicles in GH receptor-deficient mice","volume":"131","author":"Slot","year":"2006","unstructured":"13. Slot KA, Kastelijn J, Bachelot A, Kelly PA, Binart N, Teerds KJ. Reduced recruitment and survival of primordial and growing follicles in GH receptor-deficient mice. Reproduction. 2006;131:525-32.","journal-title":"Reproduction"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/humrep\/14.3.628","article-title":"Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations","volume":"14","author":"Mendoza","year":"1999","unstructured":"14. Mendoza C, Cremades N, Ruiz-Requena E, Martinez F, Ortega E, Bernabeu S, et al. Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations. Hum Reprod. 1999;14:628-35.","journal-title":"Hum Reprod"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/humrep\/17.4.1017","article-title":"Follicular fluid markers of oocyte developmental potential","volume":"17","author":"Mendoza","year":"2002","unstructured":"15. Mendoza C, Ruiz-Requena E, Ortega E, Cremades N, Martinez F, Bernabeu R, et al. Follicular fluid markers of oocyte developmental potential. Hum Reprod. 2002;17:1017-22.","journal-title":"Hum Reprod"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.fertnstert.2015.11.026","article-title":"Does the addition of growth hormone to the in vitro fertilization\/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial","volume":"105","author":"Bassiouny","year":"2016","unstructured":"16. Bassiouny YA, Dakhly DMR, Bayoumi YA, Hashish NM. Does the addition of growth hormone to the in vitro fertilization\/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial. Fertil Steril. 2016;105:697-702.","journal-title":"Fertil Steril"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ijgo.2015.05.034","article-title":"Addition of growth hormone to the microflare stimulation protocol among women with poor ovarian response","volume":"131","author":"Bayoumi","year":"2015","unstructured":"17. Bayoumi YA, Dakhly DM, Bassiouny YA, Hashish NM. Addition of growth hormone to the microflare stimulation protocol among women with poor ovarian response. Int J Gynaecol Obstet. 2015;131:305-8.","journal-title":"Int J Gynaecol Obstet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00404-012-2655-1","article-title":"Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology","volume":"287","author":"Eftekhar","year":"2013","unstructured":"18. Eftekhar M, Aflatoonian A, Mohammadian F, Eftekhar T. Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology. Arch Gynecol Obstet. 2013;287:1017-21.","journal-title":"Arch Gynecol Obstet"},{"key":"ref18","unstructured":"19. Lattes K, Brassesco M, Gomez M, Checa MA. Low-dose growth hormone supplementation increases clinical pregnancy rate in poor responders undergoing in vitro fertilisation. Gynecol Endocrinol. 2015;31:565-8."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12958-020-00632-w","article-title":"The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials","volume":"18","author":"Yang","year":"2020","unstructured":"20. Yang P, Wu R, Zhang H. The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2020;18:76.","journal-title":"Reprod Biol Endocrinol"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejogrb.2018.06.035","article-title":"The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomized control trial","volume":"228","author":"Dakhly","year":"2018","unstructured":"22. Dakhly DMR, Bassiouny YA, Bayoumi YA, Hassan MA, Gouda HM, Hassan AA. The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomized control trial. Eur J Obstet Gynecol Reprod Biol. 2018;228:161-5.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tjog.2020.10.003","article-title":"Efficacy of growth hormone supplementation with ultrashort GnRH antagonist in IVF\/ICSI for poor responders; randomized controlled trial","volume":"60","author":"Mohammad","year":"2021","unstructured":"23. Mohammad EH, Abou El Serour AG, Mohamed EAH, Abbasy AH, Zaatar M, Rageh KA, et al. Efficacy of growth hormone supplementation with ultrashort GnRH antagonist in IVF\/ICSI for poor responders; randomized controlled trial. Taiwan J Obstet Gynecol. 2021;60:51-5.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.31557\/APJCP.2019.20.7.2033","article-title":"Growth Hormone (GH) Improvement of Ovarian Responses and Pregnancy Outcome in Poor Ovarian Responders: A Randomized Study","volume":"20","author":"Safdarian","year":"2019","unstructured":"24. Safdarian L, Aghahosseini M, Alyasin A, Samaei Nouroozi A, Rashidi S, Shabani Nashtaei M, et al. Growth Hormone (GH) Improvement of Ovarian Responses and Pregnancy Outcome in Poor Ovarian Responders: A Randomized Study. Asian Pac J Cancer Prev. 2019;20:2033-7.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref24","unstructured":"25. Zafardoust S, Ansaripor S, Karimi A, Hosseinirad H, Ataei M. Effects of Adjuvant Growth Hormone Therapy on Poor Ovarian Responders in Assisted Reproductive Technology. Maedica (Bucur). 2022;17:336-43."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12958-020-00648-2","article-title":"Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomized controlled trial","volume":"18","author":"Gong","year":"2020","unstructured":"26. Gong Y, Zhang K, Xiong D, Wei J, Tan H, Qin S. Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomized controlled trial. Reprod Biol Endocrinol. 2020;18:91.","journal-title":"Reprod Biol Endocrinol"},{"key":"ref26","unstructured":"27. Zhuang GL, Wong SX, Zhou CQ. [The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer]. Zhonghua Fu Chan Ke Za Zhi. 1994;29:471-4, 510."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00404-017-4613-4","article-title":"Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study","volume":"297","author":"Choe","year":"2018","unstructured":"28. Choe SA, Kim MJ, Lee HJ, Kim J, Chang EM, Kim JW, et al. Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study. Arch Gynecol Obstet. 2018;297:791-6.","journal-title":"Arch Gynecol Obstet"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/humrep\/10.1.40","article-title":"Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study","volume":"10","author":"Dor","year":"1995","unstructured":"29. Dor J, Seidman DS, Amudai E, Bider D, Levran D, Mashiach S. Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study. Hum Reprod. 1995;10:40-3.","journal-title":"Hum Reprod"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3389\/fendo.2019.00892","article-title":"Low Dose Growth Hormone Adjuvant Treatment With Ultra-Long Ovarian Stimulation Protocol in Poor Responders Showed Non-inferior Pregnancy Outcome Compared With Normal Responders","volume":"10","author":"Lee","year":"2019","unstructured":"30. Lee YX, Shen MS, Tzeng CR. Low Dose Growth Hormone Adjuvant Treatment With Ultra-Long Ovarian Stimulation Protocol in Poor Responders Showed Non-inferior Pregnancy Outcome Compared With Normal Responders. Front Endocrinol (Lausanne). 2019;10:892.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.rbmo.2019.02.003","article-title":"Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate","volume":"38","author":"RJ","year":"2019","unstructured":"31. Norman RJ, Alvino H, Hull LM, Mol BW, Hart RJ, Kelly TL, et al; LIGHT investigators. Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate. Reprod Biomed Online. 2019;38:908-15.","journal-title":"Reprod Biomed Online"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/oxfordjournals.humrep.a137372","article-title":"Co-treatment with growth hormone of sub-optimal responders in IVF-ET","volume":"6","author":"Owen","year":"1991","unstructured":"32. Owen EJ, West C, Mason BA, Jacobs HS. Co-treatment with growth hormone of sub-optimal responders in IVF-ET. Hum Reprod. 1991;6:524-8.","journal-title":"Hum Reprod"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0015-0282(16)58217-X","article-title":"Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology","volume":"65","author":"Suikkari","year":"1996","unstructured":"33. Suikkari A, MacLachlan V, Koistinen R, Sepp\u00e4l\u00e4 M, Healy D. Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertil Steril. 1996;65:800-5.","journal-title":"Fertil Steril"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0015-0282(16)56825-3","article-title":"Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study","volume":"62","author":"Bergh","year":"1994","unstructured":"34. Bergh C, Hillensj\u00f6 T, Wikland M, Nilsson L, Borg G, Hamberger L. Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertil Steril. 1994;62:113-20.","journal-title":"Fertil Steril"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1093\/humrep\/dei066","article-title":"Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone","volume":"20","author":"Tesarik","year":"2005","unstructured":"35. Tesarik J, Hazout A, Mendoza C. Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone. Hum Reprod. 2005;20:2536-41.","journal-title":"Hum Reprod"}],"container-title":["Journal of Turkish Society of Obstetric and Gynecology"],"original-title":[],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T06:30:25Z","timestamp":1726209025000},"score":1,"resource":{"primary":{"URL":"https:\/\/tjoddergisi.org\/articles\/the-effects-of-growth-hormone-supplementation-in-poor-ovarian-responders-undergoing-in-vitro-fertilization-or-intracytoplasmic-sperm-injection-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials\/doi\/tjod.galenos.2024.59944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":35,"URL":"https:\/\/doi.org\/10.4274\/tjod.galenos.2024.59944","relation":{},"ISSN":["1307-699X","2149-9330"],"issn-type":[{"value":"1307-699X","type":"print"},{"value":"2149-9330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]}}}